Han, S.H., Kim, S.H., Kim, H.J., Lee, Y., Choi, S.Y., Park, G., Kim, D.H., Lee, A., Kim, J., Choi, J.M., Kim, Y., Myung, K., Kim, H., Kim, D.W. (2017) Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia. Leukemia. 31(7):1532-1539
|
Lernoux, M., Schnekenburger, M., Losson, H., Vermeulen, K., Hahn, H., Gérard, D., Lee, J.Y., Mazumder, A., Ahamed, M., Christov, C., Kim, D.W., Dicato, M., Bormans, G., Han, B.W., Diederich, M. (2020) Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells. Clinical epigenetics. 12:69
|
Losson, H., Gajulapalli, S.R., Lernoux, M., Lee, J.Y., Mazumder, A., Gérard, D., Seidel, C., Hahn, H., Christov, C., Dicato, M., Kirsch, G., Han, B.W., Schnekenburger, M., Diederich, M. (2020) The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia. Pharmacological research. 160:105058
|
Song, S., Lee, J.Y., Ermolenko, L., Mazumder, A., Ji, S., Ryu, H., Kim, H., Kim, D.W., Lee, J.W., Dicato, M., Christov, C., Schnekenburger, M., Cerella, C., Gérard, D., Orlikova-Boyer, B., Al-Mourabit, A., Diederich, M. (2020) Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia. Cell Death & Disease. 11:109
|
Xu, M., Ye, Y., Ye, Z., Xu, S., Liu, W., Xu, J., Zhang, Y., Liu, Q., Huang, Z., Zhang, W. (2019) Human BCR/ABL1 induces chronic myeloid leukemia-like disease in zebrafish. Haematologica. 105(3):674-686
|
Zizioli, D., Bernardi, S., Varinelli, M., Farina, M., Mignani, L., Bosio, K., Finazzi, D., Monti, E., Polverelli, N., Malagola, M., Borsani, E., Borsani, G., Russo, D. (2021) Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms. Cells. 10(2):
|
